20509 results for «»
20509 results
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
IVUS-guided left main / left main bifurcation with Megatron
09 Oct 2021 – From AICT-AsiaPCR 2021
How to optimise outcome when treating complex lesions like left main? Watch this session to find out more about the new tools that can help! You will also learn how to overcome the complexities of left main / left main bifurcations with new technologies, and you will be proposed a...
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
08 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT trial, find out more about the clinical study design and results, get acquainted with the new insights of its clinical outcome for high bleeding risk patients, and learn how the results bridge the gap and cover the unmet need for data...
Vascular access management in the cathlab
08 Oct 2021 – From AICT-AsiaPCR 2021
Get tips and tricks to improve your vessel management in the cathlab, including learning when ultrasound for vascular access can be helpful, which vessel closure device best suits you, and how to minimize complications with vascular closure devices.
#1 - How are MitraClip experience and proven outcomes influencing real-life clinical practice?
19 Oct 2021
Discover the replay of this PCR Webinar on MitraClip with H. Ince, S. Kar, W. Rottbauer and R. von Bardeleben
Delivering what matters: hypertension management with renal denervation and management of high bleeding risk patients undergoing complex PCI
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session mainly focused on renal denervation to find out more about its latest evidence, to learn about its safety profile, and to review patient-centred clinical judgment and individualised treatment plans.
#2 - Transcatheter Mitral Valve therapy : repair or replace?
19 Oct 2021
Watch the replay of this PCR Webinar on mitral valve with R. Bekeredjian, F. Maisano, F. Praz and P. Sorajja.
Tips and tricks to tackle complex bifurcation lesions (left main and non left main)
09 Oct 2021 – From AICT-AsiaPCR 2021
This session will be of great value to you if you are looking for effective ways to best manage complex bifurcation lesions! More specifically, watch it if you wish to rapidly develop a patient-specific understanding of bifurcation lesions and treatment optimisation with physiology and IVUS co-registration, to...
Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel
26 Oct 2021
An active surveillance programme was initiated by the Israeli Ministry of Health to ascertain the possible causal relationship between the vaccine and myocarditis and evaluate incidence, clinical relevance, and related outcomes.
Reviewer
Left main bifurcation with DK crush technique
09 Oct 2021 – From AICT-AsiaPCR 2021
Don't miss this session from AICT-AsiaPCR 2021 if you wish to understand how imaging can help in strategising the PCI procedure in a calcified vessel, or to be familiar with how to perform bifurcation PCI of left main and LAD/D1 with two-stent technique, among others!
ACTIVATION (percutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
19 Oct 2021
In conducting the ACTIVATION trial, Redwood and colleagues seek to complement the existing literature with high-level evidence on whether percutaneous coronary intervention (PCI) prior to TAVR is non-inferior to conservative (no PCI) management.
Reviewer
Reviewer
Cases on calcified lesions
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover various interesting cases on calcified lesions, such as a spiral coronary dissection due to intravascular balloon lithotripsy rupture, a CHIP case of recalcitrant coronary calcium, and more!
Cases on imaging
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of cases on imaging, and learn more about the prognostic utility of quantitative flow ratio in DEB-only PCI, the algorithmic approach for myocardial infarction with non-obstructive coronary arteries, as well as the advantages of OCT for primary PCI.
FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG
12 Nov 2021
Examination of the study methodology and results according to the PICOT principle, SWOT analysis and real-world applicability of the FAME 3 trial presented at TCT 2021.
FAVOR III China: Angiographic quantitative flow ratio-guided coronary intervention - a multicentre, randomised, sham-controlled trial
04 Nov 2021
Nicola Ryan provides her take on this investigator initiated, multicentre, randomised, blinded, sham controlled trial compares clinical outcomes of QFR versus angiography guided strategies for the treatment of non-critical lesions in patients with stable or unstable angina or MI at least 72 hours prior to screening....
Author
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes
04 Nov 2021
TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...
Author
Author
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency
04 Nov 2021
Elad Asher reviews the EROSION III trial, presented by Haibo Jia, which studied whether OCT guidance compared with angiographic guidance only is associated with lower stent rate implantation during pPCI in STEMI patients with non-obstructive stenosis.
Author
RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration
04 Nov 2021
Panos Xaplanteris review the RADIANCE-HTN Study, presented by Ajay Kirtane, an international randomized, sham-controlled clinical trial evaluating the safety and efficacy of renal denervation (RDN) in a population of treatment-resistant hypertensive patients.
Author
iFR-SWEDEHEART: iFR vs FFR-Guided Coronary Revascularisation
04 Nov 2021
Nicola Ryan reviews the iFR Swedeheart multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) for enrolment randomisation and follow up. At one year follow up iFR guided revascularisation was shown to be non-inferior to FFR guided revascularisation, these results...
Author
